Carbamazepine (CBZ) and zonisamide (ZNS) are antiepileptic drugs (AEDs) with multiple mechanisms of action, including inhibition of voltage-dependent sodium and calcium channels, enhancement of inhibitory events mediated by GABAergic neurotransmission, and blockade of the glutamatergic neurotransmission in the brain. Recently, the intracellular signaling pathways have been implicated as the new targets of AEDs. Especially, we have investigated the functional importance of Ca 2+ mobilization, composed of influx through Ca 2+ channels and output through ryanodine receptor (RyR)-and inositol-triphosphate receptor (IP3R)-sensitive intracellular Ca
2+-induced Ca 2+ releasing systems (CICRs), in the pathogenesis of epilepsy and the pharmacological mechanism of AEDs.